Mineralys CCO sells 7,437 shares at $25.9767
Mineralys Therapeutics, Inc. (MLYS) reported that Chief Commercial Officer Eric Warren exercised stock options and sold the resulting shares on August 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Mineralys Therapeutics, Inc. (MLYS) reported that Chief Commercial Officer Eric Warren exercised stock options and sold the resulting shares on August 21, 2026. He exercised 7,437 stock options at an exercise price of $13.24 per share into 7,437 shares of common stock, then sold 7,437 shares at a weighted‑average price of $25.9767 per share in multiple trades. Following the option exercise, he held 238,001 stock options directly. These transactions were effected pursuant to a Rule 10b5‑1 stock selling plan adopted on March 27, 2026.
Insider Trade Summary 10b5-1
Exercise and Sale: 7,437 shares ($95K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Warren Eric
Role
Chief Commercial Officer
Sold
7,437 shs ($193K)
Approx. gross sale proceeds
$193K
Approx. exercise cost
$98K
Approx. pre-tax spread
$95K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F3 | 7,437 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 7,437 | $13.24 | $98K |
| Sale | Common Stock F1, F2 | 7,437 | $25.9767 | $193K |
Holdings After Transaction:
Stock Option — 238,001 contracts (Direct);
Common Stock — 38,400 shares (Direct)
Footnotes (3)
- F1. These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026.
- F2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.82 to $26.15. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- F3. The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Key Figures
Options exercised: 7,437 shares
Exercise price: $13.24 per share
Shares sold: 7,437 shares
+5 more
8 metrics
Options exercised
7,437 shares
Stock options exercised into common stock on August 21, 2026
Exercise price
$13.24 per share
Exercise price of stock option converted on August 21, 2026
Shares sold
7,437 shares
Common shares sold on August 21, 2026 following option exercise
Weighted-average sale price
$25.9767 per share
Weighted-average price for 7,437 shares sold in multiple trades
Sale price range
$25.82–$26.15 per share
Price range of individual trades included in the weighted-average
Stock options held after transaction
238,001 options
Directly held options following the reported exercise
Rule 10b5-1 plan adoption date
March 27, 2026
Date on which the stock selling plan governing these trades was adopted
Option expiration date
April 21, 2035
Expiration of the exercised stock option
Key Terms
Rule 10b5-1 stock selling plan, weighted-average price, stock option, vesting
4 terms
Rule 10b5-1 stock selling plan regulatory
"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan"
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
stock option financial
"The stock option vested as to 25% of the underlying shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting financial
"with the remaining shares vesting in 36 substantially equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MLYS report for Chief Commercial Officer Eric Warren?
Eric Warren exercised 7,437 stock options at $13.24 per share into 7,437 common shares and sold 7,437 shares on August 21, 2026 at a weighted‑average price of $25.9767 per share, all reported as direct holdings.
How many stock options does Eric Warren hold after the August 21, 2026 MLYS transactions?
After the August 21, 2026 transactions, Eric Warren held 238,001 stock options directly, according to the reported post‑transaction option balance.
Were Eric Warren’s MLYS stock sales under a Rule 10b5-1 plan?
Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5‑1 stock selling plan adopted on March 27, 2026.
What are the terms of the MLYS stock option that Eric Warren exercised?
The exercised stock option had an exercise price of $13.24 per share and an expiration date of April 21, 2035. It vested 25% on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
